About AN2 Therapeutics (ANTX)
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The Company is focused on advancing its first product candidate, epetraborole, a once... Read more
- USD1.13
- USD1.15
- USD1.08
- USD3.07
- -7.50%
- --
- 39.22k
- 269.55k
- 32M
- 0.87
- -46.10%
Stock News
5 hours ago
Grupo Aeroportuario del Pacifico Announces Approval of Maximum Tariffs and Capital Development Program for 2026-2030 for Kingston Airport in Jamaica
Yahoo
5 hours ago
Excluding Federal Government Jobs, Payrolls Grow By 161,000 In May, Wages Jump, Despite All Moaning And Groaning
SeekingAlpha
5 hours ago
Markets Weekly Outlook - U.S. Inflation On Deck As Trade Uncertainty Lingers
SeekingAlpha
yesterday
The S&P 500 isn’t changing for now. Did this company get snubbed?
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
